US Patent Issued to HEBEI TELLGEN LIFE SCIENCE on Dec. 2 for "Fungal (1,3)-beta-d glucan-directed monoclonal antibody, coding genes thereof, expression thereof and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,317, issued on Dec. 2, was assigned to HEBEI TELLGEN LIFE SCIENCE Co. LTD. (Shijiazhuang, China).

"Fungal (1,3)-beta-d glucan-directed monoclonal antibody, coding genes thereof, expression thereof and application thereof" was invented by Bo Peng (Shijiazhuang, China), Shaochen Tan (Shijiazhuang, China) and Ning Li (Shijiazhuang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides a fungal (1,3)-Beta-D glucan-directed monoclonal antibody, coding genes thereof, expression thereof and application thereof and belongs to the technical area of medicine & biomedical detection. The antibody contains complementarity determini...